Latest Breaking News On - Zuma1 - Page 1 : comparemela.com

Following their discussion on axicabtagene ciloleucel and lisocabtagene maraleucel, panelists reflect on the real-world use of CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma.

Real world useCell therapyDiffuse largeb cell lymphomaRelapsed refractory dlbclRr dlbclSecond line therapySecond line treatmentLater line therapyLater line treatmentCart cell therapyCart therapyDisease burdenBurden of diseaseZuma 1Real world dataPatient factors